Davita Inc vs Global Payments Inc — how do they compare? Davita Inc trades at $175.04 (market cap $11.28B), while Global Payments Inc trades at $82.81 (market cap $21.46B). The key difference: Global Payments Inc is the larger of the two by market cap, and Global Payments Inc pays a 1.23% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and Global Payments Inc for 50 Days on average.
| DVA | GPN | |
|---|---|---|
Market Cap | $11.28B | $21.46B |
Volume | 650,294 | 1,482,600 |
Sector | Health | Financials |
52-Week High | $240.96 | $94.83 |
52-Week Low | $103.87 | $62.47 |
Typical Hold Time | 113 Days | 50 Days |
Enterprise Value | $24.00B | $39.60B |
Dividend Yield | — | 1.23% |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $177.02, down 1.87% on the day, showing mixed technical signals with a bearish moving average trend but neutral oscillators. Fundamentally, the company demonstrates strong earnings beats with Q2 2026 EPS of $4.02 exceeding expectations of $3.88, while revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026. Recent developments include expanding value-based care partnerships with Humana, potentially benefiting over 10,000 Medicare Advantage members.
The outlook remains cautiously optimistic with 43% analyst buy ratings and a $235.67 consensus price target suggesting 33% upside. However, rising debt-to-asset ratios (65.55% in 2025) and margin pressures from Q2 2026 create headwinds. Key risks include regulatory changes in healthcare reimbursement and competitive pressures in dialysis services.
Global Payments (GPN) trades at $81.08, down 0.87% with bearish technical signals and neutral oscillators. The company shows mixed fundamentals with a P/E of 38.43 and negative net income margin of -9.15%, though recent quarters beat EPS estimates. Revenue declined to $7.71B in 2025 from $10.1B in 2024, while debt-to-asset ratio rose to 41.57%. Positive developments include Genius platform expansion and Worldpay integration driving growth opportunities.
The stock faces headwinds from declining profitability and rising debt, but analyst consensus remains bullish with a $102.75 price target representing 27% upside. Key risks include competitive pressures and execution challenges with new initiatives. Institutional interest persists with recent position increases by HSBC and Bank of New York Mellon.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Global Payments is a leading provider of payment processing and software solutions and focuses on serving small and midsize merchants. The company operates in 30 countries and generates about one fourth of its revenue from outside North America, primarily in Europe and Asia. In 2019, Global Payments merged with Total System Services in an all-stock deal that gave Total System Services shareholders 48% of the combined company's shares.
Read more on GPN →